Callum Scott | Senior Vice President, Development
Scancell Ltd.

Dr. Callum Scott is Senior Vice President of Development at Scancell Ltd., where he leads the strategic and operational delivery of the company’s development portfolio, including CMC, Regulatory Affairs, Nonclinical Development, Clinical Supply, Programme Management, and cross-functional collaboration with Clinical Operations and Quality Assurance. Callum has over 15 years of experience in the development of biologics, including vaccines and immunotherapies, across human and animal health. He has led programmes across the full development lifecycle, from preclinical and early clinical development through Phase 3 studies, regulatory submission, approval, and lifecycle management. His work focuses on translating scientific innovation into clinically and commercially viable products by aligning scientific strategy with operational execution and commercial priorities. He has a track record of addressing complex scientific, technical, and operational challenges, enabling programmes to progress within ambitious timelines while maintaining scientific rigour, regulatory compliance, product quality, and patient safety. He holds a PhD in Molecular Microbiology, is a Chartered Fellow of the Royal Society of Biology (FRSB), and is a member of TOPRA.